Abstract
Introduction: Despite the increasing availability of Hepatitis C (HCV) anti-viral therapy for adults, there is minimal data regarding treatment safety and efficacy during pregnancy. Case Report: A 33-year-old primiparous female underwent successful HCV treatment with direct-acting antivirals (DAAs) beginning at 26 weeks gestational age. Conclusion: This case demonstrates the effective treatment of HCV during pregnancy. Formal trials are still required to assess the long-term safety and efficacy as treatment with DAAs for Hepatitis C is not yet established in pregnancy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Case Reports and Images in Obstetrics and Gynecology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
